Ophthalmic Business News

NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, AnnMarie Hipsley, DPT, PhD, founder and CEO of Ace Vision Group, discusses the company’s product pipeline, including a product launch and clinical trial.

NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Yolande Barnard, vice president and general manager, U.S. Pharmaceuticals, Bausch + Lomb, discusses Xipere (triamcinolone acetonide injectable suspension).

The FDA has approved an abbreviated new drug application for difluprednate ophthalmic emulsion 0.05%, the generic version of Durezol, according to a press release from Amneal Pharmaceuticals.

NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Greg Kunst, president and CEO of Aurion Biotech, discusses the potential of the company’s technology to work toward cures for corneal endothelial disease.

NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Mohamed Abou Shousha, MD, discusses the launch and capabilities of new diagnostic technology platforms, including the Heru re:Vive.

NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Warren Foust, worldwide president of surgical vision at J&J Vision, discusses recent IOL launches and the work the company is doing with Women in Ophthalmology.

The MINIject MIGS device has been approved in Europe for patients with open-angle glaucoma, according to a press release from iSTAR Medical.

NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Monty Montoya, CEO of TherOptix, discusses the company’s upcoming plans and explains its novel bandage contact lens platform.

Avellino Lab USA named Jon Robson as its new CEO and member of the board of directors, according to a company press release.

NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Rajesh K. Rajpal, MD, chief medical officer and global head of clinical and medical affairs at Johnson & Johnson Vision, offers insights on myopia.